Dr. Alejandro Malbrán
Equipo Medico
Institucional
Información para pacientes
Investigación
International Asthma Services
 
 
 
 
:: Dr.Alejandro Malbran
   
 
Dr.Alejandro Malbran | Curriculum Vitae | Premios | Referencias | Publicaciones
   
  PUBLICACIONES
   
 

Increased lymphocyte viability after non-stimulated peripheral blood mononuclear cell (PBMC) culture in patients with X-linked lymphoproliferative disease (XLP). Belmonte L, Parodi C, Bastón M, Coraglia A, Felippo M, Baré P, Malbrán A, Ruibal-Ares B, de E de Bracco MM.

Case report: diffuse plane xanthoma with low C4 and systemic inflammatory symptoms. Malbrán A, Parra LS, Casas JG, Malbrán E, Yeyati E, Magariños G, Marini MA.

Acute edema blisters in a hereditary angioedema cutaneous attack. Fernández Romero D, Di Marco P, Malbrán A.

A 12-week placebo-controlled study of rupatadine 10 mg once daily compared with cetirizine 10 mg once daily, in the treatment of persistent allergic rhinitis. Fantin S, Maspero J, Bisbal C, Agache I, Donado E, Borja J, Mola O, Izquierdo I; international Rupatadine study group.

[Penicillin allergy: real or consequence of?] Malbrán A, Yeyati E, Rey GL.

Cross-talk between CD31 and the signaling lymphocytic activation molecule-associated protein during interferon- gamma production against Mycobacterium tuberculosis. Quiroga MF, Jurado JO, Martínez GJ, Pasquinelli V, Musella RM, Abbate E, Issekutz AC, Bracco MM, Malbran A, Sieling PA, Chuluyan E, García VE.

Rupatadine in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled multicentre study. Gimenez-Arnau A, Pujol RM, Ianosi S, Kaszuba A, Malbran A, Poop G, Donado E, Perez I, Izquierdo I, Arnaiz E; Rupatadine Urticaria Study Group.

[Ocular penfigoid scar] Malbran A, Devote MH.

Activation of signaling lymphocytic activation molecule triggers a signaling cascade that enhances Th1 responses in human intracellular infection. Quiroga MF, Martínez GJ, Pasquinelli V, Costas MA, Bracco MM, Malbrán A, Olivares LM, Sieling PA, García VE.

Expression of signaling lymphocytic activation molecule-associated protein interrupts IFN-gamma production in human tuberculosis. Pasquinelli V, Quiroga MF, Martínez GJ, Zorrilla LC, Musella RM, Bracco MM, Belmonte L, Malbrán A, Fainboim L, Sieling PA, García VE.

Loss of circulating CD27+ memory B cells and CCR4+ T cells occurring in association with elevated EBV loads in XLP patients surviving primary EBV infection. Malbran A, Belmonte L, Ruibal-Ares B, Baré P, Massud I, Parodi C, Felippo M, Hodinka R, Haines K, Nichols KE, de Bracco MM.

[Images in medicine. Job's Syndrome] Malbrán A, Rey G, Yeyati EL.

[Registry of the primary immunodeficiencies] Feldman G, Craviotto R, Zelazko M, Rivas ME, Giraudi V, Malbrán A, Pérez N.

Complement subcomponent C1q stimulates Ig production by human B lymphocytes. Young KR Jr, Ambrus JL Jr, Malbran A, Fauci AS, Tenner AJ.

Partial neutralization of a lupus anticoagulant by human immunoglobulin. Carreras LO, Pérez GN, Martinuzzo ME, Malan-Borel I, Malbrán A, Said PB.

[The complement system in chronic Chagas disease] Riera NE, Malbrán A, Ritacco V, Cossio PM, Arana RM, de Bracco MM.

 

   
 
   
Av. Roque Saenz Peña 1160 1° "B" | C1035AAT - Buenos Aires - Argentina | Tel. (54-11) 4382.8302 / 7093 | unidaddealergia@gmail.com
Dr. Alejandro Malbrán | Equipo Médico | Institucional | Info para Pacientes | Investigación | International Asthma Services | Contáctenos